Get started
Keyword

cardiotoxicity

Description: Cardiotoxicity is harmful damage or dysfunction affecting the heart’s electrical activity or muscle function, often associated with drugs or chemicals.
Wikidata ID: wiki/Q2118956
OpenAlex ID: keywords/cardiotoxicity
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 · Yung-Jue Bang, Eric Van Cutsem, et al. · The Lancet · 7,299
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
2005 · Edward H. Romond, Edith A. Perez, et al. · New England Journal of Medicine · 5,360
PDF
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
2005 · Martine J. Piccart-Gebhart, Marion Procter, et al. · New England Journal of Medicine · 5,088
PDF
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 · Giorgio Minotti, Pierantonio Menna, et al. · Pharmacological Reviews · 3,782
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
2018 · Julie R. Brahmer, Christina Lacchetti, et al. · Journal of Clinical Oncology · 3,705
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
2022 · Alexander R Lyon, Teresa López-Fernández, et al. · European Heart Journal · 3,095
PDF
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 · Jose Luis Zamorano, Patrizio Lancellotti, et al. · European Heart Journal · 2,544
PDF
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 · José Baselga, Javier Cortés, et al. · New England Journal of Medicine · 2,526
PDF
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 · Oktay Tacar, Pornsak Sriamornsak, et al. · Journal of Pharmacy and Pharmacology · 2,465
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
1979 · DANIEL D. VON HOFF, MAXWELL W. LAYARD, et al. · Annals of Internal Medicine · 2,391
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
2021 · Bryan J. Schneider, Jarushka Naidoo, et al. · Journal of Clinical Oncology · 2,315
PDF
Congestive heart failure in patients treated with doxorubicin
2003 · Sandra M. Swain, Fredrick S. Whaley, et al. · Cancer · 2,313
PDF
Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals
2000 · Harry Olson, Graham Betton, et al. · Regulatory Toxicology and Pharmacology · 2,049
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 · Sui Zhang, Xiaobing Liu, et al. · Nature Medicine · 1,951
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
2020 · Samik Bindu, Somnath Mazumder, et al. · Biochemical Pharmacology · 1,925
PDF
Doxorubicin-Induced Cardiomyopathy
1998 · Pawan K. Singal, Natasha Iliskovic · New England Journal of Medicine · 1,850
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
2016 · Jose Luis Zamorano, Jose Luis Zamorano, et al. · European Journal of Heart Failure · 1,795
PDF
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 · Rabbab Oun, Yvonne E. Moussa, et al. · Dalton Transactions · 1,739
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
2004 · M.E.R. O’Brien, N. Wigler, et al. · Annals of Oncology · 1,739
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 · I F Tannock, D Osoba, et al. · Journal of Clinical Oncology · 1,580
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 · Andrew Seidman, Clifford Hudis, et al. · Journal of Clinical Oncology · 1,563
Doxorubicin: The Good, the Bad and the Ugly Effect
2009 · Cristina Carvalho, Renato Santos, et al. · Current Medicinal Chemistry · 1,504
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
2006 · Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, et al. · New England Journal of Medicine · 1,403
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
2016 · Marco Demaria, Monique N. O'Leary, et al. · Cancer Discovery · 1,326
PDF
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
2009 · Yogeshkumar Malam, Marilena Loizidou, et al. · Trends in Pharmacological Sciences · 1,318
Works count: 50,090
Citation count: 905,300
Year
Topic
Type